multiple sclerosis

Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Fierce Biotech
Sun, 11/14/21 - 10:52 pm
CRISPR
gene editing
Vanderbilt
multiple sclerosis
allergies
IBD
A remyelinating agent remains a distant hope
EP Vantage
Thu, 10/14/21 - 10:56 am
Atara
ATA188
remyelination
multiple sclerosis
MS
Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
PM Live
Wed, 10/13/21 - 10:47 am
Biogen
MS
multiple sclerosis
COVID-19
vaccines
Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says
Fierce Pharma
Mon, 09/27/21 - 11:04 am
Biogen
Humana
multiple sclerosis
charity
legal
Roche and Temedica Pilot Digital Companion for MS Patients
BioSpace
Wed, 09/15/21 - 10:18 pm
Roche
Temedica
MS
multiple sclerosis
devices
mobile apps
Biogen builds MS pipeline via $125m deal with China’s InnoCare
Pharmaforum
Tue, 07/13/21 - 10:39 am
Biogen
MS
multiple sclerosis
China
InnoCare
After FDA rejection, EU says yes to Sanofi’s Aubagio in kids with MS
Pharmaforum
Mon, 06/21/21 - 11:03 am
Sanofi
Aubatio
MS
multiple sclerosis
FDA
Europe
Novartis plots 'next frontier' of MS treatment — and it could spell a buyout for a small Swiss player
Endpoints
Tue, 06/1/21 - 11:10 am
Novartis
MS
multiple sclerosis
CLS12311
Cellerys
Roche's virtual gala raises multiple sclerosis awareness with celebrities—and personal connections
Fierce Pharma
Sun, 04/25/21 - 01:46 pm
Roche
Genentech
pharma marketing
multiple sclerosis
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Endpoints
Fri, 04/16/21 - 09:57 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Here's a Multibillion-Dollar Market for Johnson & Johnson
Motley Fool
Tue, 04/13/21 - 10:26 am
JNJ
Ponvory
MS
multiple sclerosis
Helius Medical’s device gets FDA all clear to stimulate the brain via the tongue
MedCity News
Mon, 04/5/21 - 10:13 pm
Helius
devices
FDA
brain stimulation
multiple sclerosis
MS
BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
BioSpace
Wed, 03/24/21 - 11:15 pm
BrainStorm Cell Therapeutics
MS
clinical trials
multiple sclerosis
J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market
Fierce Pharma
Fri, 03/19/21 - 10:56 am
JNJ
Ponvory
Novartis
Bristol-Myers Squibb
MS
multiple sclerosis
Bristol Myers Squibb's MS innovation challenge winners tap technology for patients
Fierce Pharma
Sun, 03/14/21 - 10:54 pm
Bristol-Myers Squibb
innovation
MS
multiple sclerosis
devices
Evolution Devices
aritificial intelligence
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Novartis
generics
Sandoz
FDA
Aubagio
multiple sclerosis
MS
Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use
Fierce Pharma
Wed, 03/3/21 - 10:58 am
Novartis
Kesimpta
MS
multiple sclerosis
MS study points to the gut microbiome as a potential source of the disease
Fierce Biotech
Mon, 02/8/21 - 10:47 am
MS
multiple sclerosis
microbiome
IL-17
Biogen to pay $22 million to resolve U.S. drug charity kickback probe
Reuters
Thu, 12/17/20 - 06:30 pm
Biogen
MS
kickbacks
Medicare
multiple sclerosis
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis

Pages